ferrous sulfur oxidizing strain Search Results


ferrous iron involved a ferrooxidans strain atcc 19859  (ATCC)
93
ATCC ferrous iron involved a ferrooxidans strain atcc 19859
Ferrous Iron Involved A Ferrooxidans Strain Atcc 19859, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ferrous iron involved a ferrooxidans strain atcc 19859/product/ATCC
Average 93 stars, based on 1 article reviews
ferrous iron involved a ferrooxidans strain atcc 19859 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
n oxide  (Toronto Research Chemicals)
88
Toronto Research Chemicals n oxide
N Oxide, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/n oxide/product/Toronto Research Chemicals
Average 88 stars, based on 1 article reviews
n oxide - by Bioz Stars, 2026-03
88/100 stars
  Buy from Supplier
ferrous oxidizers  (Zijin Copper Co Ltd)
90
Zijin Copper Co Ltd ferrous oxidizers
Ferrous Oxidizers, supplied by Zijin Copper Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ferrous oxidizers/product/Zijin Copper Co Ltd
Average 90 stars, based on 1 article reviews
ferrous oxidizers - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ferrous sulfur oxidizing strain  (ATCC)
97
ATCC ferrous sulfur oxidizing strain
Ferrous Sulfur Oxidizing Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ferrous sulfur oxidizing strain/product/ATCC
Average 97 stars, based on 1 article reviews
ferrous sulfur oxidizing strain - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier
roflumilast-n-oxide  (Nycomed)
90
Nycomed roflumilast-n-oxide
Roflumilast N Oxide, supplied by Nycomed, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roflumilast-n-oxide/product/Nycomed
Average 90 stars, based on 1 article reviews
roflumilast-n-oxide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
roflumilast n-oxide  (Takeda)
90
Takeda roflumilast n-oxide
Roflumilast N Oxide, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roflumilast n-oxide/product/Takeda
Average 90 stars, based on 1 article reviews
roflumilast n-oxide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
roflumilast  (Nycomed)
90
Nycomed roflumilast
Roflumilast, supplied by Nycomed, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roflumilast/product/Nycomed
Average 90 stars, based on 1 article reviews
roflumilast - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
roflumilast  (ALTANA Inc)
90
ALTANA Inc roflumilast
Roflumilast, supplied by ALTANA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roflumilast/product/ALTANA Inc
Average 90 stars, based on 1 article reviews
roflumilast - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
roflumilast or roflumilast-n-oxide  (TSE GmbH)
90
TSE GmbH roflumilast or roflumilast-n-oxide
Roflumilast Or Roflumilast N Oxide, supplied by TSE GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roflumilast or roflumilast-n-oxide/product/TSE GmbH
Average 90 stars, based on 1 article reviews
roflumilast or roflumilast-n-oxide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
roflumilast  (Dawley Inc)
90
Dawley Inc roflumilast
Roflumilast, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roflumilast/product/Dawley Inc
Average 90 stars, based on 1 article reviews
roflumilast - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
roflumilast and roflumilast n-oxide  (ALTANA Inc)
90
ALTANA Inc roflumilast and roflumilast n-oxide
Time course of the geometric mean (68% range) plasma concentrations of <t>roflumilast</t> (linear scale) . R alone: roflumilast 500 μg once daily at steady state (Regimen A: Day 11; n = 12); RF: roflumilast 500 μg once daily and formoterol 24 μg twice daily at steady state (Regimen A: Day 18; n = 12); FR: formoterol 24 μg twice daily and roflumilast 500 μg once daily at steady state (Regimen B: Day 18; n = 12).
Roflumilast And Roflumilast N Oxide, supplied by ALTANA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roflumilast and roflumilast n-oxide/product/ALTANA Inc
Average 90 stars, based on 1 article reviews
roflumilast and roflumilast n-oxide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
roflumilast-n-oxide  (MyBiosource Biotechnology)
90
MyBiosource Biotechnology roflumilast-n-oxide
Time course of the geometric mean (68% range) plasma concentrations of <t>roflumilast</t> (linear scale) . R alone: roflumilast 500 μg once daily at steady state (Regimen A: Day 11; n = 12); RF: roflumilast 500 μg once daily and formoterol 24 μg twice daily at steady state (Regimen A: Day 18; n = 12); FR: formoterol 24 μg twice daily and roflumilast 500 μg once daily at steady state (Regimen B: Day 18; n = 12).
Roflumilast N Oxide, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roflumilast-n-oxide/product/MyBiosource Biotechnology
Average 90 stars, based on 1 article reviews
roflumilast-n-oxide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Time course of the geometric mean (68% range) plasma concentrations of roflumilast (linear scale) . R alone: roflumilast 500 μg once daily at steady state (Regimen A: Day 11; n = 12); RF: roflumilast 500 μg once daily and formoterol 24 μg twice daily at steady state (Regimen A: Day 18; n = 12); FR: formoterol 24 μg twice daily and roflumilast 500 μg once daily at steady state (Regimen B: Day 18; n = 12).

Journal: BMC Clinical Pharmacology

Article Title: No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open-label, randomised, actively controlled study

doi: 10.1186/1472-6904-11-7

Figure Lengend Snippet: Time course of the geometric mean (68% range) plasma concentrations of roflumilast (linear scale) . R alone: roflumilast 500 μg once daily at steady state (Regimen A: Day 11; n = 12); RF: roflumilast 500 μg once daily and formoterol 24 μg twice daily at steady state (Regimen A: Day 18; n = 12); FR: formoterol 24 μg twice daily and roflumilast 500 μg once daily at steady state (Regimen B: Day 18; n = 12).

Article Snippet: Determination of roflumilast and roflumilast N-oxide was performed at Altana Pharma AG, Konstanz, Germany (Nycomed GmbH).

Techniques: Clinical Proteomics

Geometric means (68% inter-percentile range) of the main pharmacokinetic variables for roflumilast and roflumilast N-oxide at steady state

Journal: BMC Clinical Pharmacology

Article Title: No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open-label, randomised, actively controlled study

doi: 10.1186/1472-6904-11-7

Figure Lengend Snippet: Geometric means (68% inter-percentile range) of the main pharmacokinetic variables for roflumilast and roflumilast N-oxide at steady state

Article Snippet: Determination of roflumilast and roflumilast N-oxide was performed at Altana Pharma AG, Konstanz, Germany (Nycomed GmbH).

Techniques:

Geometric means (68% inter-percentile range) of the main pharmacokinetic variables for formoterol at steady state

Journal: BMC Clinical Pharmacology

Article Title: No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open-label, randomised, actively controlled study

doi: 10.1186/1472-6904-11-7

Figure Lengend Snippet: Geometric means (68% inter-percentile range) of the main pharmacokinetic variables for formoterol at steady state

Article Snippet: Determination of roflumilast and roflumilast N-oxide was performed at Altana Pharma AG, Konstanz, Germany (Nycomed GmbH).

Techniques:

Time course of the median cardiac output (CO) estimated by transthoracic impedance cardiography throughout the main profiling days . Regimen A: baseline Day 1 (NO treatment), Day 11 (R alone: roflumilast 500 μg once daily) and Day 18 (RF: roflumilast 500 μg once daily and formoterol 24 μg twice daily). Regimen B: baseline Day 1 (NO treatment), Day 8 (F alone: formoterol 24 μg twice daily) and Day 18 (FR: formoterol 24 μg twice daily and roflumilast 500 μg once daily).

Journal: BMC Clinical Pharmacology

Article Title: No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open-label, randomised, actively controlled study

doi: 10.1186/1472-6904-11-7

Figure Lengend Snippet: Time course of the median cardiac output (CO) estimated by transthoracic impedance cardiography throughout the main profiling days . Regimen A: baseline Day 1 (NO treatment), Day 11 (R alone: roflumilast 500 μg once daily) and Day 18 (RF: roflumilast 500 μg once daily and formoterol 24 μg twice daily). Regimen B: baseline Day 1 (NO treatment), Day 8 (F alone: formoterol 24 μg twice daily) and Day 18 (FR: formoterol 24 μg twice daily and roflumilast 500 μg once daily).

Article Snippet: Determination of roflumilast and roflumilast N-oxide was performed at Altana Pharma AG, Konstanz, Germany (Nycomed GmbH).

Techniques:

Time course of the median total peripheral resistance (TPR) estimated by transthoracic impedance cardiography throughout the main profiling days . Regimen A: baseline Day 1 (NO treatment), Day 11 (R alone: roflumilast 500 μg once daily) and Day 18 (RF: roflumilast 500 μg once daily and formoterol 24 μg twice daily). Regimen B: baseline Day 1 (NO treatment), Day 8 (F alone: formoterol 24 μg twice daily) and Day 18 (FR: formoterol 24 μg twice daily and roflumilast 500 μg once daily).

Journal: BMC Clinical Pharmacology

Article Title: No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open-label, randomised, actively controlled study

doi: 10.1186/1472-6904-11-7

Figure Lengend Snippet: Time course of the median total peripheral resistance (TPR) estimated by transthoracic impedance cardiography throughout the main profiling days . Regimen A: baseline Day 1 (NO treatment), Day 11 (R alone: roflumilast 500 μg once daily) and Day 18 (RF: roflumilast 500 μg once daily and formoterol 24 μg twice daily). Regimen B: baseline Day 1 (NO treatment), Day 8 (F alone: formoterol 24 μg twice daily) and Day 18 (FR: formoterol 24 μg twice daily and roflumilast 500 μg once daily).

Article Snippet: Determination of roflumilast and roflumilast N-oxide was performed at Altana Pharma AG, Konstanz, Germany (Nycomed GmbH).

Techniques:

Time course of the median heart rate throughout the main profiling days . Regimen A: baseline Day 1 (NO treatment), Day 11 (R alone: roflumilast 500 μg once daily) and Day 18 (RF: roflumilast 500 μg once daily and formoterol 24 μg twice daily). Regimen B: baseline Day 1 (NO treatment), Day 8 (F alone: formoterol 24 μg twice daily) and Day 18 (FR: formoterol 24 μg twice daily and roflumilast 500 μg once daily).

Journal: BMC Clinical Pharmacology

Article Title: No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open-label, randomised, actively controlled study

doi: 10.1186/1472-6904-11-7

Figure Lengend Snippet: Time course of the median heart rate throughout the main profiling days . Regimen A: baseline Day 1 (NO treatment), Day 11 (R alone: roflumilast 500 μg once daily) and Day 18 (RF: roflumilast 500 μg once daily and formoterol 24 μg twice daily). Regimen B: baseline Day 1 (NO treatment), Day 8 (F alone: formoterol 24 μg twice daily) and Day 18 (FR: formoterol 24 μg twice daily and roflumilast 500 μg once daily).

Article Snippet: Determination of roflumilast and roflumilast N-oxide was performed at Altana Pharma AG, Konstanz, Germany (Nycomed GmbH).

Techniques: